Ignite Creation Date:
2024-05-05 @ 11:25 PM
Last Modification Date:
2024-10-26 @ 10:33 AM
Study NCT ID:
NCT01324232
Status:
COMPLETED
Last Update Posted:
2021-11-22
First Post:
2011-03-23
Brief Title:
Safety and Efficacy of AVP-923 in the Treatment of Central Neuropathic Pain in Multiple Sclerosis
Sponsor:
Avanir Pharmaceuticals
Organization:
Avanir Pharmaceuticals
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-09-08
Start Date Type:
ACTUAL
Primary Completion Date:
2013-09-26
Primary Completion Date Type:
ACTUAL
Completion Date:
2013-09-26
Completion Date Type:
ACTUAL
First Submit Date:
2011-03-23
First Submit QC Date:
March 25 2011
Study First Post Date:
2011-03-28
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2021-11-22
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
2018-01-08
Disp First Submit QC Date:
January 8 2018
Disp First Post Date:
2018-01-11
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2021-10-22
Last Update Post Date:
2021-11-22
Last Update Post Date Type:
ACTUAL